- Filed
- Jun 8, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 423.08M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 390.38M sh |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2026 | $35.79M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $385.52K |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2026 | $4.12M |
| Cash And Equivalents restated | Q1 2026 · Dec 31, 2025 | $11.86M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2026 | $33.85M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2025 | $22.66M |
| Current Liabilities restated | Q1 2026 · Mar 31, 2026 | $38.07M |
| Current Liabilities restated | Q1 2026 · Dec 31, 2025 | $40.47M |
| Total Liabilities restated | Q1 2026 · Mar 31, 2026 | $38.92M |
| Total Liabilities restated | Q1 2026 · Dec 31, 2025 | $41.36M |
| Current Assets restated | Q1 2026 · Mar 31, 2026 | $68.19M |
| Current Assets restated | Q1 2026 · Dec 31, 2025 | $58.3M |
| Total Assets restated | Q1 2026 · Mar 31, 2026 | $72.81M |
| Total Assets restated | Q1 2026 · Dec 31, 2025 | $64.05M |
| Eps Diluted restated | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic restated | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense restated | Q1 2026 · Mar 31, 2026 | $4.32M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $2.14M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $0 |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $0 |
| Net Income restated | Q1 2026 · Mar 31, 2026 | $6.87M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $292.81K |
| Operating Income restated | Q1 2026 · Mar 31, 2026 | $6.86M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $407.85K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $11.63M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $2.86M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $3.58M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $3.12M |
| Revenue | Q1 2026 · Mar 31, 2026 | $15.21M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $5.98M |
| Stock Issued | Q1 2026 · Feb 17, 2022 | 96.78M sh |